Eli Lilly’s momentum stems from blockbuster GLP-1 therapies (Mounjaro, Zepbound), fuelling revenue growth, long-term margin expansion, and an ethos driving America’s health focus across ...

Investors in Eli Lilly and Company LLY need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $400.00 Call had some of the highest ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

Charleston, WV (February 2, 2025) – A pedestrian was struck by a vehicle at the intersection of Lilly Dr and Sugar Creek Dr on Sunday morning. Emergency responders arrived at the scene at ...

We don't have a problem with forecasting. It's just—this market is quite different." Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's The question of just how ...

Boris Becker's ex-wife Lilly has won the German version of I'm A Celebrity... Get Me Out Of Here! after stealing the hearts of the nation. The former Wimbledon tennis star, 57, has endured a ...

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes ...

Eli Lilly and Company (NYSE: LLY) announced results from the VIVID-2 open-label extension study, which showed the majority of patients with moderately to severely active Crohn's disease receiving ...

Seventh grade: Jeffrey Baker, Sika Banini, Karter Brimner, Addison Caulk, Zachary Cecil, Parker Cobb, Brandtley Combs, Maddax Davis, Eleah Ennis, Allison Fehrenbacher ...